John H. Abeles is an American-based venture investor, director, consultant, entrepreneur, and philanthropist.
[citation needed] He was a director of the International Opera Alliance, New York[1] and was a member of The Players Club, a theatre-themed social club.
[2] He served on the advisory board of the College of Chemistry at University of California, Berkeley.
He is chairman of UniMedica Inc.[3] Abeles is the founder and chairman of BryoLogyx, which licensed a synthetic form of bryostatin-1 from Stanford University for the use in cancer immunotherapy and adjunctive therapy.
[4] Abeles has three children (David, Lynne and Daniel), all successful NYC performing artists in drama and music as well as four granddaughters and two grandsons.